Company / Net Debt per Share
IONIS PHARMACEUTICALS INC Net Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$9.12
FY2025
5-year range
$6.40 / $9.12
FY2022-FY2025
Trend
+30.2%
vs FY2024
Sector context
#20 of 82
Health Care
What the data says
IONIS PHARMACEUTICALS INC's net debt per share of $9.12 is higher than 76% of companies in the Health Care sector (FY2025). Increased from $6.40 to $9.12 over the past 2 years.
Based on SEC 10-K filings.
9.12 in FY2025 with a 3-year CAGR of +12.0%. Top quartile in the Health Care sector.
Increased from $6.40 to $9.12 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 82This company $9.12 Sector average $1.13
▼
+706.9% above sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 30.2% year-over-year.
- Ranks #20 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.12 | +30.2% |
| FY2024 | $7.00 | +9.4% |
| FY2023 | $6.40 | -1.5% |
| FY2022 | $6.50 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026